A review of 74 scientific studies has examined the relationship between different types of alcoholic beverages and liver health, identifying variations in reported outcomes for beer, wine and spirits. Published in the journal Nutrients, the review found that heavy alcohol consumption was associated with liver damage regardless of the type of beverage consumed. However, some differences were observed at low-to-moderate levels of consumption.
The researchers analysed 74 studies, including 56 preclinical and 18 clinical investigations, to assess the effects of beer, wine and liquor on liver health. Alcohol consumption is associated with alcohol-related liver disease, which can develop from fatty liver to more serious conditions, including cirrhosis. The review noted that much of the existing research has focused on the amount and frequency of alcohol consumption, with comparatively limited evidence on the effects of individual beverage types.
The findings indicated that liquor consumption generally showed the strongest association with adverse liver outcomes, followed by beer and wine. However, the researchers noted that differences in alcohol concentration, consumption patterns and other lifestyle factors need to be considered when interpreting these findings.
Grainotch Industries Wins Two Silver Medals at ProWine & ProSpirits Challenge 2026 in Mumbai
ProWine Mumbai 2026 Enters Final Day, Bringing Global Wine and Spirits Industry Leaders to MumbaiSome preclinical studies examined antioxidant components found in certain beers, including compounds associated with hops. However, other available studies linked beer consumption with poorer liver outcomes, particularly among individuals with existing health conditions. The authors identified the need for further research into the relationship between beer composition and liver health.
Wine consumption, particularly red wine, appeared to have a comparatively lower association with adverse liver outcomes in some low-to-moderate consumption studies. However, most human studies were observational, making it difficult to establish whether these differences were directly related to wine or influenced by dietary and lifestyle factors. The review also clarified that red wine should not be considered beneficial for liver health on the basis of the available evidence.
The researchers highlighted gaps in understanding the relationship between beverage type and metabolic dysfunction-associated steatotic liver disease with increased alcohol intake (MetALD). They also called for further investigation into binge drinking and its association with liver-related outcomes.
The review concluded that heavy alcohol consumption is associated with liver damage irrespective of beverage type. The authors emphasised that abstaining from alcohol or consuming it infrequently in small quantities is likely to be the better option for health. They also noted that further clinical research is required to establish clearer differences between beer, wine and spirits.

